- Revolutionizing your traditional communication and marketing strategies to adapt to the online world
- Ensuring your social media projects fit within FDA guidelines
- Engaging your organization to use the latest social media tools to maximize effectiveness, increase productivity, inspire innovation, and advance your culture
- Developing a social media (blogging, podcasting, wiki, social network, etc.) strategy to improve your communication and marketing initiatives and practices
- Managing the continued regulatory challenges that companies face when expanding their social media footprint
- Determining the right social media mix for your organization
- Leveraging Web 2.0 technologies to build a brand culture internally and externally
- Using Twitter to turn your employees and stakeholders into brand ambassadors
- Understanding how these new social media technologies work including legal considerations, IT support, policy and guidelines
- Creating an opportunity for employees to communicate with customers directly and informally
- Outlining key steps and strategies for setting up and managing an effective social media platform
- Integrating new social media tools with traditional media to multiply your results
- Harnessing the collaborative power of your organization's social media platform to drive organizational performance
- Building senior management support for your social media programs
- Determining the Web 2.0 spaces that have relevance for your organization and brand
- Measuring the value of your organization's social media strategy: determining key metrics and gathering employee and/or customer feedback
- Creating a stronger sense of community and brand for your organization
- Building the business case and demonstrating the ROI of your social media program
- Monitoring customer feedback and satisfaction
- Marketing your social media programs both internally and externally to encourage their use
- Discovering an untapped audience and potential business opportunities
WHY IS THIS A CAN'T MISS EVENT? SMART PHARMA HAS GONE SOCIAL!
Several organizations are making dramatic strides in developing approaches and systems that work for them. The periodic sharing of these experiences and "best practices" is an important element in this social media evolution. That is why this forum, presented by the Advanced Learning Institute, is such a valuable opportunity to hear perspectives and share experiences of other pharmaceutical professionals engaged in the "journey."
Novo Nordisk Inc.
U.S. Food and Drug Administration
Johnson & Johnson
Astellas Pharma US, Inc.
Vertex Pharmaceuticals, Inc
Columbia University Medical Center
Advanced BioHealing, Inc.
Sanofi-Aventis U.S., LLC
Millennium Pharmaceuticals, Inc.
Hill & Knowlton
Pharma Marketing Blog
Featuring a Special Presentation by:
Julie Zawisza, Director of the Center for Drug Evaluation and Research’s (CDER), Office of Training and Communication, at the U.S. Food and Drug Administration, oversees CDER’s public outreach and communications programs. From 2005-2006 she was FDA acting Assistant Commissioner for Public Affairs, and from 2006-2008 FDA Assistant Commissioner for Public Affairs, where she directed FDA’s agency-wide public affairs and media relations initiatives and programs. She has more than 25 years experience in both federal government and in the private sector in healthcare communications, regulatory affairs, public policy, public relations and healthcare delivery.
Paul Buckman is the Director of Online Communications within CDER’s Office of Communications at the U.S. Food and Drug Administration, where his responsibilities include providing strategic direction and leadership for their web site. aul has extensive experience developing web-related information strategies and launching creative content for a variety of audiences. Before joining CDER, Paul was the Director of Broadband Programming for Scripps Networks Interactive in Knoxville, TN. Paul has more than 10 years of network experience and has produced and developed a wide range of online content for MSNBC.com, the Today Show, Weekend Today, and Dateline NBC which included producing live broadcast events and coordinating breaking news events for the Web.
Peter Pitts is Partner/Director of Global Regulatory Policy & Health Initiatives at Porter Novelli and President of the Center for Medicine in the Public Interest. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management, and is a Special Government Employee (SGE) consultant to the FDA’s Risk Communications Advisory Committee. His comments and commentaries on health care policy issues regularly appear in the nation’s largest news publications and programs.